Document Detail


Personalized medicine - trends in molecular diagnostics: exponential growth expected in the next ten years†.
MedLine Citation:
PMID:  21469770     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Companion diagnostics and stratified medicines will be increasingly used over the next ten years. Current market leaders who have created diagnostic divisions with a focus on biomarker identification will benefit, notably Abbott, AstraZeneca, Novartis, and GlaxoSmithKline. Pricing incentives and improvement in efficacy will drive this market. The US FDA is not likely to mandate stratification of medications, but cost containment for clinical trials will be sufficient incentive for companies to pursue this approach. The next area expected to produce stratified medicines is infectious disease, expanding from HIV to hepatitis C and hepatitis B. Celera is likely to be first to market with diagnostics for genetic variations in hepatitis C and hepatitis B. Metabolic disorders, especially diabetes, are also fertile ground for stratified medicine, likely to catch up to oncology and infectious disease over the next decade. †Adapted and reproduced from Hoggatt J. Personalized Medicine: Trends in Molecular Diagnostics. Exponential Growth Expected in the Next Ten Years. inThought Research, 2011 Feb 9.
Authors:
Julie Hoggatt
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Molecular diagnosis & therapy     Volume:  15     ISSN:  1177-1062     ISO Abbreviation:  Mol Diagn Ther     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-04-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101264260     Medline TA:  Mol Diagn Ther     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  53-5     Citation Subset:  IM    
Affiliation:
inThought Research, Wolters Kluwer Pharma Solutions, Yardley, Pennsylvania, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparative Evaluation of the ViroSeq™ HIV-1 Genotyping System and an In-House Method for Analysis...
Next Document:  Efficient Measurement of Quantum Dynamics via Compressive Sensing.